Search Results

Return to List
Results 1–20 of 20
Sort By: Relevance | Date | Title
1.

Carrier Screening for Fragile X Syndrome

Committee Opinion Number 469, October 2010

(Reaffirmed 2014, Replaces No. 338, June 2006)

October 2010

PDF Format
2.

Cell-free DNA Screening for Fetal Aneuploidy

Committee Opinion Number 640, September 2015

(This Committee Opinion Replaces Committee Opinion Number 545)

September 2015

PDF Format
3.

Comprehensive Sexuality Education

Committee Opinion Number 678, November 2016

November 2016

PDF Format
4.

Direct-to-Consumer Marketing of Genetic Testing

Committee Opinion Number 409, June 2008

Reaffirmed 2016

June 2008

PDF Format
5.

Ethical Issues in Genetic Testing

Committee Opinion Number 410, June 2008

(Reaffirmed 2014)

June 2008

PDF Format
6.

Family History as a Risk Assessment Tool

Committee Opinion Number 478, March 2011

(Reaffirmed 2015)

March 2011

PDF Format
7.

Hereditary Cancer Syndromes and Risk Assessment

Committee Opinion Number 634, June 2015

June 2015

PDF Format
8.

Identification and Referral of Maternal Genetic Conditions in Pregnancy

Committee Opinion Number 643, October 2015

October 2015

PDF Format
9.

Management of Women With Phenylketonuria

Committee Opinion Number 636, June 2015

(Replaces Committee Opinion Number 449, December 2009)

June 2015

PDF Format
10.

Maternal–Fetal Surgery for Myelomeningocele

Committee Opinion Number 550, January 2013

Reaffirmed 2015

January 2013

PDF Format
11.

Microarrays and Next-Generation Sequencing Technology: The Use of Advanced Genetic Diagnostic Tools in Obstetrics and Gynecology

Committee Opinion Number 682, December 2016

(Replaces Committee Opinion Number 581, December 2013)

December 2016

PDF Format
12.

Newborn Screening and the Role of the Obstetrician-Gynecologist

Committee Opinion Number 616, January 2015

(Replaces Committee Opinion Number 481, March 2011)

January 2015

PDF Format
13.

Personalized Genomic Testing for Disease Risk

Committee Opinion Number 527, June 2012

(Reaffirmed 2016)

June 2012

PDF Format
14.

Pharmacogenetics

Committee Opinion Number 488, May 2011

(Reaffirmed 2015)

May 2011

PDF Format
15.

Preconception and Prenatal Carrier Screening for Genetic Diseases in Individuals of Eastern European Jewish Descent

Committee Opinion Number 442, October 2009

(Reaffirmed 2014, Replaces No. 298, August 2004)

October 2009

PDF Format
16.

Screening for Tay - Sachs Disease

Committee Opinion Number 318, October 2005

(Reaffirmed 2014, Replaces No. 162, November 1995)

October 2005

PDF Format
17.

Spinal Muscular Atrophy

Committee Opinion Number 432, May 2009

Reaffirmed 2014

May 2009

PDF Format
18.

Umbilical Cord Blood Banking

Committee Opinion Number 648, December 2015

(Replaces Committee Opinion Number 399, February 2008)

December 2015

PDF Format
19.

Update on Carrier Screening for Cystic Fibrosis

Committee Opinion Number 486, April 2011

(Reaffirmed 2014, Replaces No. 325, December 2005)

April 2011

PDF Format
20.

Von Willebrand Disease in Women

Committee Opinion Number 580, December 2013

(Replaces No. 451, December 2009, Reaffirmed 2015)

December 2013

PDF Format

American Congress of Obstetricians and Gynecologists
409 12th Street SW, Washington, DC  20024-2188 | Mailing Address: PO Box 70620, Washington, DC 20024-9998